Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Clinical trial NCT01582009 · TERMINATED

Trial details

NCT number

NCT01582009

Sponsor

Roswell Park Cancer Institute

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2010-03-01

Primary completion

2015-10-01

Enrollment

26

View on ClinicalTrials.gov